Trial intelligence / Profile preview

Standard vs reduced dose naloxone for reversal of opiate overdose

2006-001384-30Phase 4Terminated

Sponsor
University Hospitals Sussex NHS Foundation Trust
Start
Jun 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of naloxone in opioid intoxication (2 arms), sponsored by University Hospitals Sussex NHS Foundation Trust. Primary endpoint: Follow-up at substance misuse service. Started Jun 2006; status: terminated.

02

Drugs

naloxone
03

Conditions

opioid intoxication

Beyond the preview

Go deeper on 2006-001384-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001384-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call